Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
Cash to Debt No Debt
EPOC's Cash to Debt is ranked lower than
99.99% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. EPOC: No Debt )
Ranked among companies with meaningful Cash to Debt only.
EPOC' s Cash to Debt Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Interest Coverage No Debt
EPOC's Interest Coverage is ranked lower than
99.99% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 69.16 vs. EPOC: No Debt )
Ranked among companies with meaningful Interest Coverage only.
EPOC' s Interest Coverage Range Over the Past 10 Years
Min: 21  Med: 5030.65 Max: No Debt
Current: No Debt
F-Score: 4
M-Score: -2.95
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
Operating margin (%) -5.30
EPOC's Operating margin (%) is ranked lower than
99.99% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. EPOC: -5.30 )
Ranked among companies with meaningful Operating margin (%) only.
EPOC' s Operating margin (%) Range Over the Past 10 Years
Min: -5.3  Med: 11.4 Max: 16.3
Current: -5.3
-5.3
16.3
Net-margin (%) -3.20
EPOC's Net-margin (%) is ranked lower than
99.99% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. EPOC: -3.20 )
Ranked among companies with meaningful Net-margin (%) only.
EPOC' s Net-margin (%) Range Over the Past 10 Years
Min: -4.9  Med: -0.1 Max: 3.7
Current: -3.2
-4.9
3.7
ROE (%) -4.30
EPOC's ROE (%) is ranked lower than
99.99% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. EPOC: -4.30 )
Ranked among companies with meaningful ROE (%) only.
EPOC' s ROE (%) Range Over the Past 10 Years
Min: -4.3  Med: -4.3 Max: -4.3
Current: -4.3
ROA (%) -2.30
EPOC's ROA (%) is ranked lower than
99.99% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: -0.39 vs. EPOC: -2.30 )
Ranked among companies with meaningful ROA (%) only.
EPOC' s ROA (%) Range Over the Past 10 Years
Min: -3.5  Med: -0.05 Max: 3
Current: -2.3
-3.5
3
» EPOC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with EPOC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:NAS:AXGN, NAS:ELOS, OTCPK:VICA, NYSE:IVC, NAS:TNDM, NAS:GNMK, NAS:EXAC, NAS:RTIX, NAS:IRMD, NAS:PAVM, NAS:XENT, AMEX:CVRS, NAS:ARAY, NAS:ACRX, NAS:EYES, OTCPK:SOMNF, NAS:CUTR, NAS:IRIX, NAS:FONR, NAS:SPNE » details


EPocrates, Inc. was incorporated in California in August 1998 as nCircle Communications, Inc. In September 1999, it changed its name to ePocrates, Inc., and in May 2006, it reincorporated in Delaware and changed its name to Epocrates, Inc. The Company is a provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry. Most commonly used on mobile devices at the point of care, its products help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity. The Company's user network consists of over one million healthcare professionals, including more than 290,000, or more than 40% of, U.S. physicians. It offers its products on all major U.S. mobile platforms including Apple (iPhone, iPod touch and iPad), Android, BlackBerry, Palm and Windows Mobile devices. The Company's proprietary drug content is the most frequently used mobile reference product and provides healthcare professionals with convenient access to information they need at the point of care. Healthcare professionals are able to access information such as dosing, drug/drug interactions, pricing and insurance coverage for thousands of brand, generic and over-the-counter drugs. Through its interactive services, it provides the healthcare industry, primarily pharmaceutical companies, access to its user network to deliver targeted information in a cost-effective manner. The Company's services include: DocAlert clinical messaging to deliver news and alerts including product approvals, clinical study results and formulary status changes; Virtual Representative Services for drug detailing, drug sampling, patient literature delivery and the ability to contact drug manufacturers at the point of care; and Market research programs to survey healthcare professionals. The healthcare industry is highly regulated and is subject to changing political, regulatory and other influences.

Ratios

vs
industry
vs
history
P/S 2.61
EPOC's P/S is ranked lower than
99.99% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 3.21 vs. EPOC: 2.61 )
Ranked among companies with meaningful P/S only.
EPOC' s P/S Range Over the Past 10 Years
Min: 1.38  Med: 2.01 Max: 15.24
Current: 2.61
1.38
15.24
PFCF 0.25
EPOC's PFCF is ranked lower than
99.99% of the 97 Companies
in the Global Medical Devices industry.

( Industry Median: 27.16 vs. EPOC: 0.25 )
Ranked among companies with meaningful PFCF only.
EPOC' s PFCF Range Over the Past 10 Years
Min: 0.25  Med: 99999999.99 Max: 99999999.99
Current: 0.25
0.25
99999999.99
EV-to-EBITDA 79.24
EPOC's EV-to-EBITDA is ranked lower than
99.99% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 18.25 vs. EPOC: 79.24 )
Ranked among companies with meaningful EV-to-EBITDA only.
EPOC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0  Med: 0 Max: 79.24
Current: 79.24
0
79.24
Current Ratio 2.20
EPOC's Current Ratio is ranked lower than
99.99% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. EPOC: 2.20 )
Ranked among companies with meaningful Current Ratio only.
EPOC' s Current Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.2
Current: 2.2
0
2.2
Quick Ratio 2.00
EPOC's Quick Ratio is ranked lower than
99.99% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. EPOC: 2.00 )
Ranked among companies with meaningful Quick Ratio only.
EPOC' s Quick Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2
Current: 2
0
2

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price/Net Cash 22.10
EPOC's Price/Net Cash is ranked lower than
99.99% of the 94 Companies
in the Global Medical Devices industry.

( Industry Median: 16.20 vs. EPOC: 22.10 )
Ranked among companies with meaningful Price/Net Cash only.
EPOC' s Price/Net Cash Range Over the Past 10 Years
Min: 11.1  Med: 22.65 Max: 76.2
Current: 22.1
11.1
76.2
Price/Net Current Asset Value 20.00
EPOC's Price/Net Current Asset Value is ranked lower than
99.99% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 7.35 vs. EPOC: 20.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
EPOC' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 10.7  Med: 18.65 Max: 29.3
Current: 20
10.7
29.3
Price/Tangible Book 6.10
EPOC's Price/Tangible Book is ranked lower than
99.99% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 4.28 vs. EPOC: 6.10 )
Ranked among companies with meaningful Price/Tangible Book only.
EPOC' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.3  Med: 5.5 Max: 8
Current: 6.1
3.3
8
Price/Median PS Value 1.40
EPOC's Price/Median PS Value is ranked lower than
99.99% of the 260 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. EPOC: 1.40 )
Ranked among companies with meaningful Price/Median PS Value only.
EPOC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.7  Med: 2.05 Max: 5.6
Current: 1.4
0.7
5.6
Earnings Yield (Greenblatt) (%) 7.50
EPOC's Earnings Yield (Greenblatt) (%) is ranked lower than
99.99% of the 305 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. EPOC: 7.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
EPOC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.2  Med: 0.85 Max: 7.5
Current: 7.5
0.2
7.5

More Statistics

Short Percentage of Float0.00%
52-Week Range $6.90 - 11.97
Shares Outstanding (Mil)24.87

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)